Loss of EPLIN may account for dysregulation of cytoskeletal dynamics, alterations of cell motility and cell-cell adhesion disruption which is believed to promote tumour proliferation, invasion and migration [14,15]. The gene discussed is LIMA1; the disease is neoplasm.